iHerb Top Wellness Trends in 2023
Dr. Michael Murray, N.D. forecasts the 2023 wellness trends on the rise on iHerb's popular blog PASADENA, Calif., Jan. 5, 2023 /PRNewswire/ -- iHerb, the largest eCommerce platform, dedicated to vitamins, minerals, and supplements has tapped Dr. Michael Murray, N.D. – one of the leading authorities in dietary supplements, and natural products –...
AMR Action Fund Announces Investment in BioVersys AG
Deal marks Fund's first investment in Europe and advances its mission of enabling the launch of two to four antimicrobials by 2030 BOSTON, Jan. 5, 2023 /PRNewswire/ -- The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicrobials, announced today that it has invested...
Yunji Successfully Concludes its New Year Festive Goods Shopping Festival
HANGZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that the final large-scale promotional event before the Lunar New Year, the New Year Festive Goods Shopping Festival ("the Event"), successfully concluded at the end of December 2022. The Event showcased and promoted Yunji's flagship...
So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, Jan. 5, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has received a written compliance notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market...
Shine-On Biomedical Co., Ltd. Accorded the International Innovation Awards 2022 for TROY CAR EXOs
SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Enterprise Asia is pleased to honor 39 remarkable innovations at the 6th International Innovation Awards (IIA) 2022. The awards took place in Bangkok, Thailand following the International Innovation Summit 2022 which convened over 300 innovation experts, industry leaders, and policymakers worldwide. As one of the pillars of the Innovation Revolution movement spearheaded by...
Oneness Biotech Co., Ltd.’s FESPIXON® Honored at the International Innovation Awards 2022
SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Enterprise Asia is pleased to honor 39 remarkable innovations at the 6th International Innovation Awards (IIA) 2022. The awards took place in Bangkok, Thailand following the International Innovation Summit 2022 which convened over 300 innovation experts, industry leaders, and policymakers worldwide. As one of the pillars of the Innovation Revolution movement spearheaded by...
Novogene Announces Deployment of Illumina NovaSeq™ X Plus and PacBio REVIO Sequencing Systems
SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Novogene, a leading provider of genomic services and solutions, announced the addition of Illumina's latest high-throughput sequencing system NovaSeq™ X Plus and PacBio's Revio™ long-read sequencing system to its lineup of sequencing platforms. These systems will be deployed in Novogene's regional lab facilities and will be available to its global customer base. Novogene is...
B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital in Tokyo
- Memorandum of Understanding Signed with Edogawa Hospital - TOKYO, Jan. 5, 2023 /PRNewswire/ -- B dot Medical Inc. has signed a memorandum of understanding with Edogawa Hospital in Japan for the installation of the company's first practical ultra-compact proton therapy system, which means the first proton therapy facility to be established in Tokyo. Logo: https://kyodonewsprwire.jp/img/202212211482-O2-n1O2n8B4 Image1: Edogawa Hospital in Tokyo, Japan https://kyodonewsprwire.jp/prwfile/release/M105528/202212211482/_prw_PI3fl_q4R7xNxK.jpeg...
Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
SUZHOU, China and ROCKVILLE, Md., Jan. 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its Chairman and CEO, Dr. Dajun Yang, has accepted an invitation to speak at the 41st Annual J.P....
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfront payment, development, regulatory and commercial milestones, and tiered royalties Collaboration based on synergies between Adcendo and Duality in generating breakthrough ADCs in hard-to-treat cancers reflecting validation and...












